Evidence map›Paper›PMID 36450351›Full record

ArticleSe pu = Chinese journal of chromatography2022

[Determination of 16 particle-phase polycyclic aromatic hydrocarbons in herbal incense by ultrasonic extraction-gas chromatography-mass spectrometry and analysis of emission characteristics].

Meizhen Cai

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Meizhen CaiNational Quality Supervision and Inspection Center for Incense Products (Fujian), Quanzhou 362600, China.
Fujian Inspection and Research Institute for Product Quality · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbons (PAHs) have attracted global attention because they are carcinogens and mutagenic to humans. To date, more than 200 PAHs have been found. The United States Environmental Protection Agency (USEPA) has designated 16 PAH species as priority control pollutants due to their highly toxic substances. Herbal incense is frequently used in daily life. As a result, it is critical to investigate its impact on human health and environmental safety. However, research on particle-phase PAHs is very limited and inapplicable. The current research focuses mainly on bamboo incense, which has a simpler formula than herbal incense.In this study, the emission factor and emission characteristics of particle-phase PAHs from herbal incense were described. A method combining ultrasonic and gas chromatography-mass spectrometry (GC-MS) was developed for the simultaneous determination of 16 particle-phase PAHs of herbal incense. The settings for extraction solvent, ultrasonic time, and instrument analysis conditions were optimized. In the test chamber, samples were collected by burning 0.8 g of herbal incense. After combustion, PAHs adsorbing on the particles of herbal incense were collected on a quartz filter. The whole filter sample was sliced and extracted with

Indexed as

PhenanthrenesPolycyclic Aromatic HydrocarbonsFluorenesGas Chromatography-Mass SpectrometryHumansUltrasonicsUnited StatesfluorantheneFluorenesphenanthrenePhenanthrenesPolycyclic Aromatic Hydrocarbonscharacteristic ratioemission characteristicsgas chromatography-mass spectrometry (GC-MS)herbal incenseparticle-phasepolycyclic aromatic hydrocarbons (PAHs)ultrasonic extraction

Identifiers

PMID36450351
PMCPMC9727747
OpenAlexW4310598024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.